Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 43
Page 30
... metabolism ) are 1A2 , 2C9 , 2E1 and 3A4 . P450s 2D6 , 2A6 and 2B6 are also present in smaller amounts , although P4502D6 is known to be responsible for the metabolism of many compounds in man27 . A different range of P450s are ...
... metabolism ) are 1A2 , 2C9 , 2E1 and 3A4 . P450s 2D6 , 2A6 and 2B6 are also present in smaller amounts , although P4502D6 is known to be responsible for the metabolism of many compounds in man27 . A different range of P450s are ...
Page 35
... metabolism . Lancet . 1994 ; 343 : 35-8 . 21. Meyer UA , Zanger UM , Grand D , Blum M. Genetic polymorphisms of drug metabolism . Adv Drug Res . 1989 ; 19 : 197–241 . 22. Kaminsky LS , Fasco MJ . Small intestinal cytochromes P450 . Crit ...
... metabolism . Lancet . 1994 ; 343 : 35-8 . 21. Meyer UA , Zanger UM , Grand D , Blum M. Genetic polymorphisms of drug metabolism . Adv Drug Res . 1989 ; 19 : 197–241 . 22. Kaminsky LS , Fasco MJ . Small intestinal cytochromes P450 . Crit ...
Page 279
... metabolism . Randomized , double blind trials have com- pared the effect of 0.5 mg betamethasone diproprionate enemas with 5 mg beclomethasone phosphate in patients with distal ulcerative colitis8-10 . The overall therapeutic response ...
... metabolism . Randomized , double blind trials have com- pared the effect of 0.5 mg betamethasone diproprionate enemas with 5 mg beclomethasone phosphate in patients with distal ulcerative colitis8-10 . The overall therapeutic response ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis